Shen Lian Biomedical released its performance for the first three quarters, with a net profit attributable to the parent company of 280,000 yuan, turning a profit compared to the same period last yearZhitong·Oct 26, 2025 at 02:37 AM688098+4.47%
Shen Lian Biomedical: UBI plans to reduce its holdings by no more than 3% of sharesZhitong·Oct 22, 2025 at 06:19 AM688098+4.47%
Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit upZhitong·Oct 16, 2025 at 08:44 PM300683+7.29%002004+0.68%
Shen Lian Biomedical has been approved for a veterinary drug product approval numberZhitong·Sep 8, 2025 at 02:51 AM688098+4.47%
Shen Lian Biomedical: The Phase II clinical study of the innovative drug UB-221 injection has completed the enrollment of all subjectsZhitong·Aug 31, 2025 at 04:54 AM688098+4.47%
Shen Lian Biomedical: Net loss of 12.8697 million yuan in the first half of 2025Zhitong·Aug 29, 2025 at 06:23 AM688098+4.47%
August 19th Midday Review: Shanghai Composite Index rises 0.3% in half a day, pharmaceutical stocks strengthen collectivelyWallstreetcn·Aug 18, 2025 at 10:30 PM600590+2.55%600218+1.35%
Shen Lian Biomedical: The innovative drug pipeline including monoclonal antibodies for AIDS is independently operated by ShizhiyuanZhitong·Aug 18, 2025 at 05:14 AM688098+4.47%
Shen Lian Biomedical: The company's production and operations are normal, with no undisclosed significant matters that need to be disclosedZhitong·Aug 18, 2025 at 03:55 AM688098+4.47%
The concept of innovative drugs is active again, Shen Lian Biomedical has achieved a two-day limit upZhitong·Aug 17, 2025 at 08:37 PM688336+3.61%688098+4.47%
Guohai Securities: The "Matthew Effect" in the animal protection industry intensifies, and pet pharmaceuticals and overseas expansion are expected to open up medium to long-term growth spaceZhitong·Aug 14, 2025 at 01:38 AM300119+1.73%688098+4.47%
Pharmaceutical stocks fell sharply, with innovative drug sector leading the declineZhitong·Aug 3, 2025 at 09:43 PM688098+4.47%
Biological vaccine stocks strengthened, among which, Shen Lian Biomedical rose over 10%, Global Printing 10CM hit the daily limit, Guanhao Biotech and Sinovac Biotech rose over 7%, Saili Medical rose over 5%, Kanglao Weishi, Jinhe Biotechnology, and Vland Biotech rose over 4%, Yongshun Biotech, Dezhan Health, Junzheng Group, and Kanghua Biotech rose over 3%Zhitong·Jul 31, 2025 at 08:50 PM300238+3.14%603739+1.26%
The animal vaccine sector continues to rise, with Shen Lian Biomedical up over 10%Zhitong·Jul 31, 2025 at 08:38 PM002688+1.00%688098+4.47%
Shen Lian Biomedical signed a cooperative development contract for a multi-valent vaccine project with the Lanzhou Institute of Animal Husbandry and Veterinary Medicine, Chinese Academy of Agricultural SciencesZhitong·Jul 31, 2025 at 03:23 AM688098+4.47%
